An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia

Improved treatments for lymphatic filariasis (LF) could accelerate the global elimination program for this disease. A triple drug combination of the anti-filarial drugs ivermectin, diethylcarbamazine (DEC) and albendazole (IDA) has been shown to be safe and effective for achieving sustained clearanc...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:PLoS Negl Trop Dis
Main Authors: Supali, Taniawati, Djuardi, Yenny, Christian, Michael, Iskandar, Elisa, Alfian, Rahmat, Maylasari, Roospita, Destani, Yossi, Lomiga, Adriani, Minggu, Dominikus, Lew, Daphne, Bogus, Joshua, Weil, Gary J., Fischer, Peter U.
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2021
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8031952/
https://ncbi.nlm.nih.gov/pubmed/33780481
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0009294
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares